Decreases in Phospholipids Containing Adrenic and Arachidonic Acids Occur in the Human Hippocampus over the Adult Lifespan

Lipids

Volumn 50, Issue 9, 2015, Pages 861-872

  Hancock, Sarah E ^a,b   Friedrich, Michael G ^a   Mitchell, Todd W ^a,b   Truscott, Roger J W ^a   Else, Paul L ^a  

^a ILLAWARRA HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Aging; ARA; DHA; Lipidomics; Mass spectrometry; Membrane; Microsome; Mitochondria; Neurodegeneration

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; ARACHIDONIC ACID DERIVATIVE; UNSATURATED FATTY ACID;

ADULT; AGE; AGED; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIFESPAN; LIPID COMPOSITION; MALE; MICROSOME; MICROSOME MEMBRANE; MITOCHONDRIAL MEMBRANE; PROTEIN CONTENT; ADOLESCENT; AGING; METABOLISM; MIDDLE AGED; MITOCHONDRION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ARACHIDONIC ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICROSOMES; MIDDLE AGED; MITOCHONDRIA; PHOSPHOLIPIDS; YOUNG ADULT;

EID: 84939774188     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-015-4030-z     Document Type: Article

References (32)

1. WHO, Alzheimer's Disease International (2012) Dementia: a public health priority. In: WHO. http://www.who.int/mental-health/publications/dementia-report-2012/en/. Accessed 12 Feb 2014
2. Kosicek M, Hecimovic S (2013) Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int J Mol Sci 14:1310-1322. doi: 10.3390/ijms14011310
3. Mapstone M, Cheema AK, Fiandaca MS et al. (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20:415-418. doi: 10.1038/nm.3466
4. Fox NC, Crum WR, Scahill RI et al (2001) Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. The Lancet 358:201-205. doi: 10.1016/S0140-6736(01)05408-3
5. Scahill RI, Schott JM, Stevens JM et al (2002) Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci 99:4703-4707. doi: 10.1073/pnas.052587399
6. Scahill RI, Frost C, Jenkins R et al (2003) A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 60:989-994. doi: 10.1001/archneur.60.7.989
7. Ewers M, Insel P, Jagust WJ et al. (2012) CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex 22:1993-2004. doi: 10.1093/cercor/bhr271
8. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol Berl 82:239-259
9. Corrigan FM, Horrobin DF, Skinner ER et al (1998) Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol 30:197-207
10. Guan Z, Wang Y, Cairns NJ et al (1999) Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol 58:740-747
11. Prasad MR, Lovell MA, Yatin M et al (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23:81-88
12. Skinner ER, Watt C, Besson JAO, Best PV (1993) Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 116:717-725. doi: 10.1093/brain/116.3.717
13. Söderberg M, Edlund C, Alafuzoff I et al (1992) Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem 59:1646-1653
14. Wells K, Farooqui AA, Liss L, Horrocks LA (1995) Neural membrane phospholipids in Alzheimer disease. Neurochem Res 20:1329-1333. doi: 10.1007/BF00992508
15. Söderberg M, Edlund C, Kristensson K, Dallner G (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26:421-425
16. Söderberg M, Edlund C, Kristensson K, Dallner G (1990) Lipid compositions of different regions of the human brain during aging. J Neurochem 54:415-423
17. O'Brien JS, Sampson EL (1965) Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res 6:537-544
18. Yetukuri L, Ekroos K, Vidal-Puig A, Orešič M (2008) Informatics and computational strategies for the study of lipids. Mol BioSyst 4:121-127. doi: 10.1039/B715468B
19. Svennerholm L (1968) Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 9:570-579
20. Martínez M, Mougan I (1998) Fatty acid composition of human brain phospholipids during normal development. J Neurochem 71:2528-2533. doi: 10.1046/j.1471-4159.1998.71062528.x
21. Blanksby SJ, Mitchell TW (2010) Advances in mass spectrometry for lipidomics. Annu Rev Anal Chem Palo Alto Calif 3:433-465. doi: 10.1146/annurev.anchem.111808.073705
22. Norris SE, Friedrich MG, Mitchell TW et al (2015) Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease. Neurobiol Aging 36:1659-1669. doi: 10.1016/j.neurobiolaging.2015.01.002
23. Liebisch G, Vizcaíno JA, Köfeler H et al (2013) Shorthand notation for lipid structures derived from mass spectrometry. J Lipid Res 54:1523-1530. doi: 10.1194/jlr.M033506
24. Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta BBA Mol Cell Biol Lipids 1486:219-231. doi: 10.1016/S1388-1981(00)00077-9
25. Brooksbank BW, Martinez M (1989) Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease. Mol Chem Neuropathol Spons Int Soc Neurochem World Fed Neurol Res Groups Neurochem Cerebrospinal Fluid 11:157-185
26. Fraser T, Tayler H, Love S (2010) Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res 35:503-513. doi: 10.1007/s11064-009-0087-5
27. Baylis D, Bartlett DB, Patel HP, Roberts HC (2013) Understanding how we age: insights into inflammaging. Longev Heal 2:8. doi: 10.1186/2046-2395-2-8
28. Kim H-Y, Akbar M, Kim Y-S (2010) Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostaglandins Leukot Essent Fat Acids PLEFA 82:165-172. doi: 10.1016/j.plefa.2010.02.025
29. Martinez M (1992) Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res 583:171-182. doi: 10.1016/S0006-8993(10)80021-6
30. Hassan-Zadeh E, Baykal-Caglar E, Alwarawrah M, Huang J (2014) Complex roles of hybrid lipids in the composition, order, and size of lipid membrane domains. Langmuir 30:1361-1369. doi: 10.1021/la4044733
31. Klose C, Surma MA, Simons K (2013) Organellar lipidomics - background and perspectives. Curr Opin Cell Biol 25:406-413. doi: 10.1016/j.ceb.2013.03.005
32. Szekely O, Schilt Y, Steiner A, Raviv U (2011) Regulating the size and stabilization of lipid raft-like domains and using calcium ions as their probe. Langmuir 27:14767-14775. doi: 10.1021/la203074q